Warfarin and SRP — NDEB AFK MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Continue warfarin at the current dose and proceed with SRP — local haemostasis is adequate for this non-surgical procedure
Scaling and root planing (non-surgical periodontal therapy) is not a high-bleeding-risk procedure. Patients on stable warfarin therapy with an INR within the therapeutic range (typically 2.0-3.0) should continue their anticoagulant and undergo SRP without modification. Local haemostatic measures (pressure, haemostatic agents if needed) are sufficient for managing any minor bleeding. The thromboembolic risk of discontinuing warfarin far exceeds the bleeding risk from periodontal scaling.
Reference: SDCEP – Management of Dental Patients Taking Anticoagulants or Antiplatelets, 2022